X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.reuters.com/world/us/us-supreme-court-abortion-pill-fight-brings-claims-distorted-science-2024-03-25/
https://www.fiercepharma.com/pharma/solicitor-general-prelogar-joins-chorus-protestors-pressing-supreme-court-nix-mifepristone
https://www.reuters.com/legal/california-sues-organizations-touting-abortion-pill-reversal-2023-09-21/
https://www.reuters.com/legal/abortion-pill-maker-loses-bid-block-west-virginias-abortion-ban-2023-08-25/
https://endpts.com/doj-plans-to-take-mifepristone-challenge-to-the-supreme-court/
https://endpts.com/house-republicans-use-fda-appropriations-bill-to-override-rems-changes-on-abortion-pill/
https://www.reuters.com/legal/abortion-pill-maker-seeks-keep-challenge-w-va-abortion-ban-alive-2023-05-23/
https://www.fox8live.com/2023/05/18/federal-appeals-court-new-orleans-holds-an-hours-long-hearing-an-fda-approved-abortion-pill/
https://www.reuters.com/legal/us-appeals-court-weigh-fate-abortion-pill-2023-05-17/
https://www.reuters.com/world/americas/us-debates-abortion-pill-ban-argentina-expands-its-use-2023-05-16/
https://endpts.com/abortion-providers-sue-fda-in-a-virginia-federal-court-over-abortion-drug-restrictions/
https://www.biopharmadive.com/news/abortion-providers-sue-mifepristone-restrictions/649819/
https://thehill.com/regulation/court-battles/3960437-supreme-court-abortion-mifepristone-fda/
https://www.reuters.com/legal/us-supreme-court-poised-act-abortion-pill-curbs-2023-04-21/
https://pharmaphorum.com/news/supreme-court-presses-pause-mifepristone-curbs
https://endpts.com/breaking-supreme-court-preserves-access-to-abortion-pill-while-other-court-cases-play-out/
https://endpts.com/abortion-pill-cant-just-snap-back-to-pre-2016-fdas-woodcock-tells-scotus/
https://www.reuters.com/article/usa-abortion-court/abortion-pill-maker-asks-u-s-supreme-court-to-stop-curbs-on-access-to-drug-idINS0N32D00Y
https://www.reuters.com/legal/abortion-pill-access-may-continue-even-if-fda-loses-us-court-battle-2023-04-12/
https://www.reuters.com/legal/some-us-abortion-pill-providers-curb-availability-after-appeals-court-ruling-2023-04-13/
https://www.reuters.com/legal/abortion-pill-opponents-urge-us-appeals-court-allow-ban-2023-04-12/
https://endpts.com/fda-may-need-to-get-creative-if-abortion-pill-approval-pulled-this-week/
https://www.reuters.com/business/healthcare-pharmaceuticals/us-drugmakers-call-reversing-texas-abortion-pill-ruling-2023-04-10/
https://www.fiercepharma.com/pharma/legal-battle-over-abortion-pill-conflicting-rulings-leave-future-access-even-more-air
https://endpts.com/texas-court-ruling-on-abortion-pill-opens-fda-and-its-approval-decisions-to-wider-political-attacks/
https://www.reuters.com/world/us/white-house-plans-support-drugstores-pharma-abortion-pill-battle-sources-2023-04-09/
https://www.reuters.com/legal/us-judge-hands-anti-abortion-groups-partial-win-over-abortion-pill-2023-04-07/
https://www.biopharmadive.com/news/abortion-pill-ruling-invalidate-fda-approval-mifepristone/645378/
https://www.prnewswire.com/news-releases/statement-in-response-to-texas-ruling-upending-fda-approval-of-mifeprex-301792784.html
https://www.reuters.com/legal/us-abortion-pill-case-fda-could-soften-blow-court-ordered-restrictions-2023-03-23/
https://www.reuters.com/legal/texas-judge-consider-banning-abortion-pill-us-2023-03-15/
https://www.reuters.com/legal/democratic-led-us-states-sue-challenge-federal-restrictions-abortion-pill-2023-02-24/
https://endpts.com/law-experts-argue-that-abortion-drug-withdrawal-would-undermine-the-approval-process/
https://www.fiercepharma.com/pharma/abortion-pill-maker-genbiopro-sues-west-virginia-over-abortion-ban
https://www.fiercepharma.com/pharma/abortion-pill-maker-genbiopro-sues-west-virginia-over-abortion-ban
https://www.fiercepharma.com/pharma/fda-pushes-back-anti-abortion-groups-lawsuit-over-abortion-pill-approval
https://www.reuters.com/world/us/reversing-abortion-drugs-approval-would-harm-public-interest-us-fda-says-2023-01-17/
https://www.fiercepharma.com/pharma/22-years-later-conservative-organization-sues-fda-approving-abortion-pill
https://endpts.com/state-battles-over-mifepristone-access-could-tie-the-fda-to-any-post-roe-crossroads/
https://thehill.com/policy/healthcare/568550-house-members-to-urge-fda-to-remove-in-person-requirement-for-abortion?rl=1
https://endpts.com/fda-dispenses-with-in-person-requirement-for-abortion-pill-access-during-the-pandemic/
https://www.forbes.com/sites/mishagajewski/2020/09/14/easing-restrictions-on-the-abortion-pill-could-help-improve-access-to-care/#5af82f201e01
https://www.forbes.com/sites/joshuacohen/2020/09/06/politicizing-safety-of-the-abortion-pill-mifeprex/#570c73d444c5
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211436
https://in.reuters.com/article/us-health-medicines-who/who-keeps-key-lung-cancer-drugs-off-its-essential-medicines-list-idINKCN1U40YS
https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?linkID=SBD00239
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211436
https://www.reuters.com/article/us-health-miscarriage-treatment/drug-combination-better-for-restoring-womb-after-miscarriage-idUSKCN1J22WA
https://www.raps.org/news-and-articles/news-articles/2018/3/gao-finds-mixed-views-on-fda-monitoring-of-abortio?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails&_zs=VHOsL1&_zl=nvxN4
Market Place
Share 
